Elevated globotriaosylsphingosine is a hallmark of Fabry disease
Amsterdam UMC Location University of Amsterdam · Endocrinology Research Center · +3 more institutions
Abstract
Fabry disease is an X-linked lysosomal storage disease caused by deficiency of alpha-galactosidase A that affects males and shows disease expression in heterozygotes. The characteristic progressive renal insufficiency, cardiac involvement, and neuropathology usually are ascribed to globotriaosylceramide accumulation in the endothelium. However, no direct correlation exists between lipid storage and clinical manifestations, and treatment of patients with recombinant enzymes does not reverse several key signs despite clearance of lipid from the endothelium. We therefore investigated the possibility that globotriaosylceramide metabolites are a missing link in the pathogenesis. We report that deacylated…
Citation impact
- FWCI
- 18.13
- Percentile
- 100%
- References
- 50
Authors
18- JMJohannes M. F. G. AertsCorresponding
Amsterdam UMC Location University of Amsterdam
- JGJ.E.M. Groener
Amsterdam UMC Location University of Amsterdam
- SKSijmen Kuiper
Amsterdam UMC Location University of Amsterdam
- WEWilma E. Donker‐Koopman
Amsterdam UMC Location University of Amsterdam
- ASAnneke Strijland
Amsterdam UMC Location University of Amsterdam
Topics & keywords
- Globotriaosylceramide
- Fabry disease
- Fabry's disease
- Sphingolipid
- Enzyme replacement therapy
- Metabolite
- Pathogenesis
- Endocrinology
- Good health and well-being